ID | Description | Set size | Enrichment core | NES | Rank |
---|---|---|---|---|---|
hsa04140 | Autophagy - animal | 127 | -0.488 | -1.840 | 3669 |
hsa04145 | Phagosome | 127 | -0.423 | -1.594 | 2572 |
hsa05169 | Epstein-Barr virus infection | 187 | -0.524 | -2.050 | 2794 |
hsa04062 | Chemokine signaling pathway | 173 | -0.454 | -1.766 | 2868 |
hsa04210 | Apoptosis | 130 | -0.432 | -1.634 | 3326 |
hsa04621 | NOD-like receptor signaling pathway | 162 | -0.423 | -1.638 | 2793 |
hsa04910 | Insulin signaling pathway | 130 | -0.443 | -1.677 | 3804 |
hsa04514 | Cell adhesion molecules | 128 | -0.464 | -1.749 | 1477 |
hsa04218 | Cellular senescence | 144 | -0.459 | -1.756 | 3332 |
hsa04142 | Lysosome | 125 | -0.515 | -1.929 | 3342 |
hsa05206 | MicroRNAs in cancer | 159 | -0.454 | -1.751 | 3033 |
hsa04936 | Alcoholic liver disease | 134 | -0.424 | -1.608 | 2460 |
hsa05152 | Tuberculosis | 165 | -0.494 | -1.916 | 2480 |
hsa05161 | Hepatitis B | 155 | -0.510 | -1.962 | 3092 |
hsa05162 | Measles | 134 | -0.520 | -1.970 | 2403 |
hsa04613 | Neutrophil extracellular trap formation | 102 | -0.556 | -2.039 | 3033 |
hsa04071 | Sphingolipid signaling pathway | 111 | -0.498 | -1.840 | 2794 |
hsa04650 | Natural killer cell mediated cytotoxicity | 110 | -0.554 | -2.041 | 3065 |
hsa04668 | TNF signaling pathway | 110 | -0.534 | -1.967 | 3122 |
hsa04931 | Insulin resistance | 104 | -0.515 | -1.886 | 3804 |
hsa04144 | Endocytosis | 222 | -0.361 | -1.429 | 2580 |
hsa04120 | Ubiquitin mediated proteolysis | 130 | -0.398 | -1.505 | 3719 |
hsa04620 | Toll-like receptor signaling pathway | 94 | -0.435 | -1.577 | 3316 |
hsa04080 | Neuroactive ligand-receptor interaction | 342 | 0.358 | 1.677 | 3930 |
hsa05012 | Parkinson disease | 220 | 0.317 | 1.416 | 1331 |
hsa04217 | Necroptosis | 122 | -0.391 | -1.465 | 3016 |
hsa01200 | Carbon metabolism | 105 | -0.408 | -1.495 | 1901 |
hsa04137 | Mitophagy - animal | 65 | -0.444 | -1.501 | 3894 |
hsa04730 | Long-term depression | 56 | -0.465 | -1.533 | 3459 |